Literature DB >> 17852221

Social Security Disability Insurance (SSDI) in Parkinson's disease.

T A Zesiewicz1, A Patel-Larson, R A Hauser, K L Sullivan.   

Abstract

OBJECTIVE: Parkinson's disease (PD) causes significant economic burden for patients and caregivers. Social Security Disability Insurance (SSDI) provides insurance to workers in the United States who have been gainfully employed, but who are no longer able to work due to a medical condition. We performed a descriptive pilot study that examined PD patients' experience with SSDI.
METHODS: PD patients who were diagnosed with PD prior to age 60 and were followed at an academic movement disorders center were consecutively invited to participate in a survey concerning their employment history and experience with SSDI.
RESULTS: All 68 invited patients participated in the study (mean age 58 years, mean disease duration 9.5 years). Eighty-two percent of patients felt that they were too disabled to work full time at a mean of 3.4 years after PD diagnosis. Patients applied for SSDI at a mean of 5 years after diagnosis, and two-thirds of PD patients who applied for SSDI obtained it on their first attempt. The primary debilitating symptom that subjectively contributed to work disability was fatigue (49% of patients). Patients who successfully acquired SSDI had extensive documentation of physician visits, and the aid of a disability lawyer.
CONCLUSIONS: Patients felt they were too disabled to work full time at a mean of 3.4 years after diagnosis. Those who applied for SSDI did so at a mean of 5 years after diagnosis. Patients who obtained SSDI awards had extensive documentation of medical records or the help of a disability lawyer.

Entities:  

Mesh:

Year:  2007        PMID: 17852221     DOI: 10.1080/09638280701257247

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  10 in total

Review 1.  Parkinson's disease-related fatigue: A case definition and recommendations for clinical research.

Authors:  Benzi M Kluger; Karen Herlofson; Kelvin L Chou; Jau-Shin Lou; Christopher G Goetz; Anthony E Lang; Daniel Weintraub; Joseph Friedman
Journal:  Mov Disord       Date:  2016-02-16       Impact factor: 10.338

2.  [Progressive supranuclear palsy: living environment of the patients in Germany].

Authors:  M Hensler; S Paul; C Abright; S Lorenzl
Journal:  Nervenarzt       Date:  2011-02       Impact factor: 1.214

Review 3.  Neuropsychiatric symptoms in Parkinson's disease.

Authors:  Dag Aarsland; Laura Marsh; Anette Schrag
Journal:  Mov Disord       Date:  2009-11-15       Impact factor: 10.338

4.  Fatigue in Parkinson's disease patients.

Authors:  Joseph H Friedman
Journal:  Curr Treat Options Neurol       Date:  2009-05       Impact factor: 3.598

5.  Reformulating psychological difficulties in people with Parkinson's disease: the potential of a social relational approach to disablism.

Authors:  Jane Simpson; Helen McMillan; Donna Reeve
Journal:  Parkinsons Dis       Date:  2013-08-13

6.  Risk Factors of Fatigue in Idiopathic Parkinson's Disease in a Polish Population.

Authors:  Monika Gołąb-Janowska; Dariusz Kotlęga; Krzysztof Safranow; Agnieszka Meller; Anna Budzianowska; Krystyna Honczarenko
Journal:  Parkinsons Dis       Date:  2016-01-26

7.  Impaired dopamine metabolism is linked to fatigability in mice and fatigue in Parkinson's disease patients.

Authors:  Débora da Luz Scheffer; Fernando Cini Freitas; Aderbal Silva Aguiar; Catherine Ward; Luiz Guilherme Antonacci Guglielmo; Rui Daniel Prediger; Shane J F Cronin; Roger Walz; Nick A Andrews; Alexandra Latini
Journal:  Brain Commun       Date:  2021-06-08

8.  Managing Fatigue in Parkinson's Disease: Protocol for a Pilot Randomized Controlled Trial.

Authors:  Neda Alizadeh; Tanya L Packer; Ingrid Sturkenboom; Gail Eskes; Grace Warner
Journal:  Can J Occup Ther       Date:  2022-03-15       Impact factor: 1.630

Review 9.  Viewpoint and practical recommendations from a movement disorder specialist panel on objective measurement in the clinical management of Parkinson's disease.

Authors:  Per Odin; K Ray Chaudhuri; Jens Volkmann; Angelo Antonini; Alexander Storch; Espen Dietrichs; Zvezdan Pirtošek; Tove Henriksen; Malcolm Horne; David Devos; Filip Bergquist
Journal:  NPJ Parkinsons Dis       Date:  2018-05-10

10.  Fatigue evaluated using the 16-item Parkinson Fatigue Scale (PFS-16) predicts Parkinson's disease prognosis.

Authors:  Yoshiki Niimi; Sayuri Shima; Yasuaki Mizutani; Akihiro Ueda; Shinji Ito; Tatsuro Mutoh
Journal:  Fujita Med J       Date:  2019-02-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.